4. Correlation of actual patients’ survival according to calculated probability of 1-year disease-specific survival (external validation). Low-risk group: the nomogram-based calculated 1-year disease-specific survival probability is <33.3%; intermediate-risk group: 33.3%−66.6%; and high-risk group: >66.6%. The survival rates were significantly different among the three groups (P=0.044).